Skip to main content
Erschienen in: Virchows Archiv 2/2009

01.02.2009 | Review and Perspective

Retroperitoneal margin of the pancreaticoduodenectomy specimen: anatomic mapping for the surgical pathologist

verfasst von: Mahmoud A. Khalifa, Vlad Maksymov, Corwyn Rowsell

Erschienen in: Virchows Archiv | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Surgical margin status of the pancreaticoduodenectomy specimen is an independent predictor of survival in patients with pancreatic head cancer. Although most surgical pathologists are familiar with the protocols for grossing and evaluation of the various margins of the specimen, the currently prevailing definitions of the retroperitoneal surgical margin minimize the fact that this margin is actually a combination of surfaces of different anatomical structures. The unfamiliarity with its detailed anatomy often creates communication gaps when the pathologic findings are presented to other members of the multidisciplinary team. The following discussion is the collective opinion of hepato-pancreato-biliary pathologists in two tertiary care Canadian medical centers in this field. It describes the authors’ proposed nomenclature and landmarks for anatomic mapping of the retroperitoneal margin of the pancreaticoduodenectomy resected specimen. Increasing familiarity with the subtleties of the retroperitoneal margin is expected to improve communication and sets the stage for future quality improvement initiatives and translational research in the multidisciplinary setting.
Literatur
1.
Zurück zum Zitat Allema JH, Reinders ME, vanGulik TM et al (1995) Prognostic factors for suvival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic region. Cancer 75:2069–2076PubMedCrossRef Allema JH, Reinders ME, vanGulik TM et al (1995) Prognostic factors for suvival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic region. Cancer 75:2069–2076PubMedCrossRef
2.
Zurück zum Zitat Fuhrman GM, Leach SD, Staley CA et al (1996) Rationale for en bloc resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg 223(2):154–162PubMedCrossRef Fuhrman GM, Leach SD, Staley CA et al (1996) Rationale for en bloc resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg 223(2):154–162PubMedCrossRef
3.
4.
Zurück zum Zitat Varadhachary GR, Tamm EP, Abbruzzese JL et al (2006) Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13:1035–1046PubMedCrossRef Varadhachary GR, Tamm EP, Abbruzzese JL et al (2006) Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13:1035–1046PubMedCrossRef
5.
Zurück zum Zitat Esposito I, Kleeff J, Bergmann F et al (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15:1651–1660PubMedCrossRef Esposito I, Kleeff J, Bergmann F et al (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15:1651–1660PubMedCrossRef
6.
Zurück zum Zitat Verbeke CS, Menon KV (2008) Variability in reporting resection margin status in pancreatic cancer. Ann Surg 247:716–717PubMedCrossRef Verbeke CS, Menon KV (2008) Variability in reporting resection margin status in pancreatic cancer. Ann Surg 247:716–717PubMedCrossRef
7.
Zurück zum Zitat Poon RT, Fan ST, Lo CM et al (2004) Pancreaticoduodenectomy with en block portal vein resection for pancreatic carcinoma with suspected portal vein involvement. World J Surg 28(6):602–608PubMedCrossRef Poon RT, Fan ST, Lo CM et al (2004) Pancreaticoduodenectomy with en block portal vein resection for pancreatic carcinoma with suspected portal vein involvement. World J Surg 28(6):602–608PubMedCrossRef
8.
Zurück zum Zitat Tseng JF, Raut CP, Lee JE et al (2004) Pancreatoduodenectomy with vascular resection; margin status and survival duration. J Gastrointest Surg 8(8):935–949PubMedCrossRef Tseng JF, Raut CP, Lee JE et al (2004) Pancreatoduodenectomy with vascular resection; margin status and survival duration. J Gastrointest Surg 8(8):935–949PubMedCrossRef
9.
Zurück zum Zitat Verbeke CS (2007) Resection margins and R1 rates in pancreatic cancer—are we there yet. Histopathology 52(7):787–796PubMedCrossRef Verbeke CS (2007) Resection margins and R1 rates in pancreatic cancer—are we there yet. Histopathology 52(7):787–796PubMedCrossRef
10.
Zurück zum Zitat Fuhrman GM, Charnsangavej C, Abbruzzese JL et al (1994) Thin-section contrast-enhanced computer tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 167:104–113PubMedCrossRef Fuhrman GM, Charnsangavej C, Abbruzzese JL et al (1994) Thin-section contrast-enhanced computer tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 167:104–113PubMedCrossRef
11.
Zurück zum Zitat Staley CA, Cleary KR, Abbruzzese JL et al (1996) The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas 12:373–380PubMedCrossRef Staley CA, Cleary KR, Abbruzzese JL et al (1996) The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas 12:373–380PubMedCrossRef
12.
Zurück zum Zitat Zamboni G, Capelli P, Pesci A et al (2000) Pancreatic head mass; what can be done? Classification: the pathological point of view. JOP.J Pancreas (on line) 1(3suppl):77–84 Zamboni G, Capelli P, Pesci A et al (2000) Pancreatic head mass; what can be done? Classification: the pathological point of view. JOP.J Pancreas (on line) 1(3suppl):77–84
14.
Zurück zum Zitat Raut CP, Tseng JF, Sun CC et al (2007) Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246(1):52–60PubMedCrossRef Raut CP, Tseng JF, Sun CC et al (2007) Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246(1):52–60PubMedCrossRef
15.
Zurück zum Zitat Khalifa MA (2007) Intraoperative assessment of the Whipple’s resection specimen. J Clin Pathol 60:975–980PubMedCrossRef Khalifa MA (2007) Intraoperative assessment of the Whipple’s resection specimen. J Clin Pathol 60:975–980PubMedCrossRef
16.
Zurück zum Zitat Khalifa MA, Maksymov V, Rowsell CH et al (2007) A novel approach to the intraoperative assessment of the uncinate margin of the pancreaticoduodenectomy specimen. Hepato Pancreato Biliary (HPB) 9:146–149 Khalifa MA, Maksymov V, Rowsell CH et al (2007) A novel approach to the intraoperative assessment of the uncinate margin of the pancreaticoduodenectomy specimen. Hepato Pancreato Biliary (HPB) 9:146–149
17.
Zurück zum Zitat Rowsell CH, Hanna S, Hsieh E et al (2007) Improved lymph node retrieval in Whipple specimens as a result of implementation of a new uncinate margin protocol. Hepato Pancreato Biliary (HPB) 9:388–391 Rowsell CH, Hanna S, Hsieh E et al (2007) Improved lymph node retrieval in Whipple specimens as a result of implementation of a new uncinate margin protocol. Hepato Pancreato Biliary (HPB) 9:388–391
18.
Zurück zum Zitat Nato M, Miwa K, Kitagawa H et al (2005) Pancreas head carcinoma: frequency of invasion to soft tissue adherent to the superior mesenteric artery. Am J Surg Pathol 29:1056–1061 Nato M, Miwa K, Kitagawa H et al (2005) Pancreas head carcinoma: frequency of invasion to soft tissue adherent to the superior mesenteric artery. Am J Surg Pathol 29:1056–1061
19.
Zurück zum Zitat Zhou GW, Wu WD, Xiao WD et al (2005) Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases. Hepatobiliary Pancreat Dis Int 4:130–134PubMed Zhou GW, Wu WD, Xiao WD et al (2005) Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases. Hepatobiliary Pancreat Dis Int 4:130–134PubMed
20.
Zurück zum Zitat Aramaki M, Matsumoto T, Etoh T et al (2003) Clinical significance of combined pancreas and portal vein resection in surgery for pancreatic adenocarcinoma. Hepatogastroenterology 50(49):263–266PubMed Aramaki M, Matsumoto T, Etoh T et al (2003) Clinical significance of combined pancreas and portal vein resection in surgery for pancreatic adenocarcinoma. Hepatogastroenterology 50(49):263–266PubMed
21.
Zurück zum Zitat Luttges J, Vogel I, Menke M et al (1998) The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch 433:237–242PubMedCrossRef Luttges J, Vogel I, Menke M et al (1998) The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch 433:237–242PubMedCrossRef
22.
Zurück zum Zitat Verbeke CS, Leitch D, Menon KV et al (2006) Redefining the R1 resection in pancreatic cancer. Br J Surg 93:1232–1237PubMedCrossRef Verbeke CS, Leitch D, Menon KV et al (2006) Redefining the R1 resection in pancreatic cancer. Br J Surg 93:1232–1237PubMedCrossRef
Metadaten
Titel
Retroperitoneal margin of the pancreaticoduodenectomy specimen: anatomic mapping for the surgical pathologist
verfasst von
Mahmoud A. Khalifa
Vlad Maksymov
Corwyn Rowsell
Publikationsdatum
01.02.2009
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 2/2009
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-008-0711-9

Weitere Artikel der Ausgabe 2/2009

Virchows Archiv 2/2009 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …